Stigma and Medication for Opioid Use Disorder (MOUD) Among Women

被引：9

作者：

Chou, Jessica L. ^{[1
]}

Patton, Rikki ^{[2
]}

Cooper-Sadlo, Shannon ^{[3
]}

Swan, Carsen ^{[3
]}

Bennett, David S. ^{[4
]}

McDowell, Dara ^{[1
]}

Zaarur, Asif ^{[1
]}

Schindler, Barbara ^{[4
]}

机构：

[1] Drexel Univ, Dept Counseling & Family Therapy, 1601 Cherry St, Philadelphia, PA 19103 USA

[2] Univ Akron, Dept Social Work, Akron, OH USA

[3] St Louis Univ, Sch Social Work, St Louis, MO USA

[4] Drexel Univ, Coll Med, Philadelphia, PA USA

来源：

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION | 2022年 / 20卷 / 06期

关键词：

Opioid use disorder; Medication for opioid use disorder; Women; SUBSTANCE USE DISORDERS; SUPPORT; HEALTH;

D O I：

10.1007/s11469-022-00768-3

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

Opioid misuse is a massive public health crisis that is impacting women. In 2019, in the USA, 15,000 women fatally overdosed from opioids. Medication for opioid use disorder (MOUD) is an effective treatment that facilitates withdrawal management which promotes recovery of opioid use disorder. Yet, the stigma associated with OUD and MOUD as a treatment keeps some women with OUD from seeking treatment. The present study analyzed focus group data to understand experiences of stigma among women with opioid OUD who were receiving MOUD. Results indicated three themes: (1) "MOUD is still a drug," (2) Responses in coping with MOUD stigma, and (3) The value of peer support in MOUD treatment. Treatment considerations for women using MOUD include psychoeducation for family members and strategies to further incorporate peer support into MOUD treatment.

引用

页码：3262 / 3273

页数：12

共 54 条

[1] Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification [J].

Amato, Laura ;

Minozzi, Silvia ;

Davoli, Marina ;

Vecchi, Simona .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (09)

[2]

[Anonymous], KEY SUBSTANCE USE ME

[3]

Bielenberg J., 2018, A systematic review of stigma interventions for addiction treatment providers

[4] Shame's Associations with Depression and Problem Drinking: An Ecological Momentary Study [J].

Bilevicius, Elena ;

Kempe, Tyler ;

Pankratz, Lily ;

Wardell, Jeffrey D. ;

Johnson, Edward A. ;

Keough, Matthew T. .

SUBSTANCE USE & MISUSE, 2021, 56 (11) :1715-1725

[5] Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification [J].

Bozinoff, Nikki ;

Anderson, Bradley J. ;

Bailey, Genie L. ;

Stein, Michael D. .

JOURNAL OF ADDICTION MEDICINE, 2018, 12 (01) :19-23

[6]

Braun V., 2006, Qual Res Psychol, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, DOI 10.1080/10875549.2021.1929659, https://doi.org/10.1191/1478088706qp063oa]

[7]

Brundage S., 2019, RIPPLE EFFECT IMPACT, DOI [10.1016/j.clinthera.2019.06.003, DOI 10.1016/J.CLINTHERA.2019.06.003]

[8] Brief Report: Gender Differences in Demographic and Clinical Characteristics of Patients with Opioid Use Disorder Entering a Comparative Effectiveness Medication Trial [J].

Campbell, Aimee N. C. ;

Barbosa-Leiker, Celestina ;

Hatch-Maillette, Mary ;

Mennenga, Sarah E. ;

Pavlicova, Martina ;

Scodes, Jennifer ;

Saraiya, Tanya ;

Mitchell, Shannon G. ;

Rotrosen, John ;

Novo, Patricia ;

Nunes, Edward V. ;

Greenfield, Shelly F. .

AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (06) :465-470

[9]

Center for Substance Abuse Treatment (CSAT), 2006, HHS PUBL

[10] Perceived stigma and social support in treatment for pharmaceutical opioid dependence [J].

Cooper, Sasha ;

Campbell, Gabrielle ;

Larance, Briony ;

Murnion, Bridin ;

Nielsen, Suzanne .

DRUG AND ALCOHOL REVIEW, 2018, 37 (02) :262-272

← 1 2 3 4 5 6 →